Skip to main content
OpenTrials

Clinical trial condition

Microsatellite Stable Colorectal Carcinoma

Explore clinical trials studying Microsatellite Stable Colorectal Carcinoma. Study availability and eligibility vary by location and protocol.

7 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Microsatellite Stable Colorectal Carcinoma trial results

Recruiting

A Study of NX-1607 in Adults With Advanced Malignancies

NCT05107674

Conditions
Adenoma, Adnexal Diseases, Breast Diseases, +75 more
Locations
  • City of Hope Duarte, California, United States
  • University of Southern California Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • University of Colorado School of Medicine Aurora, Colorado, United States
View all 17 locations
View Trial Details
Recruiting

Sequential Immunochemotherapy Treatment with Pembrolizumab Plus Dendritic Cell (DC) Vaccine Followed by Trifluridine/Tipiracil Plus Bevacizumab in Refractory Mismatch-repair-proficient (pMMR) or Microsatellite-stable (MSS) Metastatic Colorectal Cancer

NCT06522919

Conditions
Colonic Diseases, Colorectal Cancer Metastatic, Colorectal Neoplasms, +11 more
Locations
  • IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori"-IRST S.r.l. Meldola, Forlì Cesena, Italy
  • Pia Fondazione di Culto e Religione Azienda Ospedaliera "Card.G.Panico" Tricase, Lecce, Italy
View Trial Details
Completed

COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies

NCT04354246

Conditions
Adnexal Diseases, Advanced Cancer, Blood Protein Disorders, +53 more
Locations
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Massachusetts General Hospital. Boston, Massachusetts, United States
  • START Midwest. Grand Rapids, Michigan, United States
  • The Ohio State University Comprehensive Cancer Center. Columbus, Ohio, United States
View Trial Details

Related conditions